Back
Accelerate Diagnostics Vs. ENDRA Life Sciences Industry Stock Comparison
Sell
32
AXDX
Accelerate Diagnostics
Last Price:
1.25
Seasonality Move:
15.49%
Sell
27
NDRA
ENDRA Life Sciences
Last Price:
0.27
Seasonality Move:
12.01%
Sell
32
Accelerate Diagnostics (AXDX)
is a Sell
Is Accelerate Diagnostics a Buy, Sell or Hold?
- The current Accelerate Diagnostics [AXDX] share price is $1.21. The Score for AXDX is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
- AXDX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
27
ENDRA Life Sciences (NDRA)
is a Sell
Is ENDRA Life Sciences a Buy, Sell or Hold?
- The current ENDRA Life Sciences [NDRA] share price is $0.27. The Score for NDRA is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
- NDRA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
AXDX Stock Price Chart
What is Accelerate Diagnostics's stock price today?
-
The Accelerate Diagnostics share price today is $1.21
The current trend is moderately bullish and AXDX is experiencing slight selling pressure.
NDRA Stock Price Chart
What is ENDRA Life Sciences's stock price today?
-
The ENDRA Life Sciences share price today is $0.27
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NDRA is experiencing selling pressure, which indicates risk of future bearish movement.
AXDX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.11 | Buy |
Relative Strength Index (14 RSI): | 57.79 | Buy |
Chaikin Money Flow: | -22581 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.83 - 1.23) | Buy |
Bollinger Bands (100): | (0.58 - 1.8) | Buy |
NDRA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.03 | Sell |
Relative Strength Index (14 RSI): | 37.65 | Sell |
Chaikin Money Flow: | -213944 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.27 - 0.31) | Sell |
Bollinger Bands (100): | (0.34 - 1.14) | Sell |
AXDX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.28 | Sell |
20-day SMA: | 1.05 | Buy |
50-day SMA: | 0.97 | Buy |
200-day SMA: | 3.39 | Sell |
8-day EMA: | 1.25 | Sell |
20-day EMA: | 1.12 | Buy |
50-day EMA: | 1.11 | Buy |
200-day EMA: | 3.19 | Sell |
NDRA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.28 | Sell |
20-day SMA: | 0.3 | Sell |
50-day SMA: | 0.37 | Sell |
200-day SMA: | 0.97 | Sell |
8-day EMA: | 0.28 | Sell |
20-day EMA: | 0.3 | Sell |
50-day EMA: | 0.43 | Sell |
200-day EMA: | 1.12 | Sell |
Accelerate Diagnostics Earnings Growth & AXDX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.89 per share, an increase next quarter of $0.12 per share, an increase this year of $3.91 per share, and an increase next year of $0.53 per share.
ENDRA Life Sciences Earnings Growth & NDRA Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.79 per share, and an increase next year of $0.02 per share.
Accelerate Diagnostics Technical Analysis
May 17 | May 20 | May 21 | May 22 | May 23 | May 24 | May 28 | May 29 | May 30 | May 31 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
17 | 20 | 21 | 22 | 23 | 24 | 28 | 29 | 30 | 31 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
ENDRA Life Sciences Technical Analysis
May 17 | May 20 | May 21 | May 22 | May 23 | May 24 | May 28 | May 29 | May 30 | May 31 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
17 | 20 | 21 | 22 | 23 | 24 | 28 | 29 | 30 | 31 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |